Intervention Protocol

You have free access to this content

Interventions for infected cysts in people with autosomal dominant polycystic kidney disease

  1. Nuria Montero1,*,
  2. Laia Sans1,
  3. Angela C Webster2,3,4,
  4. Julio Pascual1

Editorial Group: Cochrane Kidney and Transplant Group

Published Online: 29 JAN 2014

DOI: 10.1002/14651858.CD010946

How to Cite

Montero N, Sans L, Webster AC, Pascual J. Interventions for infected cysts in people with autosomal dominant polycystic kidney disease (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010946. DOI: 10.1002/14651858.CD010946.

Author Information

  1. 1

    Hospital del Mar-IMIM, Department of Nephrology, Barcelona, Spain

  2. 2

    The University of Sydney, Sydney School of Public Health, Sydney, NSW, Australia

  3. 3

    The University of Sydney at Westmead, Centre for Transplant and Renal Research, Westmead Millennium Institute, Westmead, NSW, Australia

  4. 4

    The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia

*Nuria Montero, Department of Nephrology, Hospital del Mar-IMIM, Passeig Marítim 25-29, Barcelona, 08003, Spain.

Publication History

  1. Publication Status: New
  2. Published Online: 29 JAN 2014



Additional references

Akinci 2008
  • Akinci D, Turkbey B, Yilmaz R, Akpinar E, Ozmen MN, Akhan O. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease. Cardiovascular & Interventional Radiology 2008;31(5):926-30. [MEDLINE: 18196333]
Alam 2009
  • Grace B, Hurst K, McDonald S. Chapter 2: New patients commencing treatments in 2010. In: ANZDATA Report 2011. (accessed 28 November 2013).
Bennett 1985
Bennett 1987
  • Bennett WM, Elzinga L, Golper TA, Barry JM. Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. Journal of Urology 1987;137(4):620-2. [MEDLINE: 2435925]
Chauveau 2000
  • Chauveau D, Fakhouri F, Grunfeld JP. Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. Journal of the American Society of Nephrology 2000;11(9):1767-75. [MEDLINE: 10966503]
Chehval 1995
Chow 2005
Desouza 2009
  • Desouza RM, Prachalias A, Srinivasan P, O'Doherty M, Olsburgh J. Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplantation Proceedings 2009;41(5):1942-5. [MEDLINE: 19545761]
Elzinga 1987
Elzinga 1988
Elzinga 1992a
Elzinga 1992b
  • Elzinga LW, Barry JM, Torres VE, Zincke H, Wahner HW, Swan S, et al. Cyst decompression surgery for autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology 1992;2(7):1219-26. [MEDLINE: 1591362]
Elzinga 1993
  • ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2009. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands. 2011. (accessed 28 November 2013).
Fick 1995
Gibson 1998
Grantham 2008
Higgins 2003
Higgins 2011
  • Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from
Hiyama 2006
Jouret 2012
  • Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, et al. Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrology Dialysis Transplantation 2012;27(10):3746-51. [MEDLINE: 23114901]
Lee 2003
  • Lee YR, Lee KB. Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease. Korean Journal of Radiology 2003;4(4):239-42. [MEDLINE: 14726641]
Levison 2004
Muther 1981
RMRC 2010
  • Arcos E, Comas J, Romero R. Registre de malalts renals de Catalunya. Statistical report 2010. (accessed 28 November 2013).
Rosenfeld 2002
  • Rosenfeld L, Bonny C, Kallita M, Heng AE, Deteix P, Bommelaer G, et al. Polycystic liver disease and its main complications [Les polykystoses hepatiques]. Gastroenterologie Clinique et Biologique 2002;26(12):1097-106. [MEDLINE: 12520197]
Rossi 1993
Saedi 2009
  • Saedi D, Varedi P, Mahmoodi S, Varedi P. Ultrasonography-guided intracystic injection of appropriate antibiotics: valuable for treatment of pyocyst in autosomal dominant polycystic kidney disease?. Iranian Journal of Kidney Diseases 2009;3(4):252. [MEDLINE: 19841533]
Sallee 2009
  • Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, Knebelmann B, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clinical Journal of The American Society of Nephrology: CJASN 2009;4(7):1183-9. [MEDLINE: 19470662]
Schwab 1983
Schwab 1985
Schwab 1986
Sklar 1987
Stiasny 2002
Tahvanainen 2005
Telenti 1990
Torres 2008
  • Torres V, Grantham J. Cystic diseases of the kidney. In: Brenner B editor(s). The kidney. Vol. 6:1428-62, Philadelphia: Saunders Elsevier, 2008.
USRDS 2011
  • Volume 2, Chapter 1: Incidence, prevalence, patient characteristics, and modalities. In: U.S. Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2011. (accessed 28 November 2013).
Waters 1979
Wilson 2004